SCHEMBL31371625

SCHEMBL31371625

C=CC(=O)N1CCC(O)(C(F)(F)F)C1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.39
▸ TET3 O43151 7/20 0.39
▸ FBXL19 Q6PCT2 7/20 0.39
▸ CXXC5 Q7LFL8 7/20 0.39
▸ KDM2B Q8NHM5 7/20 0.39
▸ CXXC4 Q9H2H0 7/20 0.39
▸ KDM2A Q9Y2K7 7/20 0.39
▸ TET1 Q8NFU7 5/20 0.39
▸ CNR2 P34972 2/20 0.35
▸ BTK Q06187 5/20 0.34
▸ TEAD1 P28347 3/20 0.32
▸ VNN1 O95497 1/20 0.32
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4228827 0.78 CNR2 (0.38) CNR2VNN1
SCHEMBL21236898 0.77 CNR2 (0.37) CNR2VNN1
SCHEMBL18069128 0.77 SMN1; SMN2 (0.42) KMT2ACNR2VNN1MAPK1
SCHEMBL24244520 0.74 KMT2A (0.42) KMT2ATET3FBXL19CXXC5KDM2B
SCHEMBL20849781 0.74 TET3 (0.45) KMT2ATET3FBXL19CXXC5KDM2B
SCHEMBL19910567 0.72 PDK2 (0.37) CNR2VNN1
SCHEMBL19910592 0.72 OPRM1 (0.45) CNR2VNN1
SCHEMBL24244455 0.72 KMT2A (0.44) KMT2ATET3FBXL19CXXC5KDM2B
SCHEMBL27896663 0.71 RORC (0.41) KMT2ACNR2VNN1
SCHEMBL4224125 0.70 USP2 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025034849-A1 FUSED PYRIDAZINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2025-02-13 — — WO disclosed
Send feedback